Critical Role of Antioxidant Programs in Enzalutamide-Resistant Prostate Cancer

To understand the metabolic alterations involved in enzalutamide resistance, scientists performed metabolomic, transcriptomic, and cistromic analyses of enzalutamide-sensitive and -resistant prostate cancer cells, xenografts, patient-derived organoids, patient-derived explants, and tumors.